Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia

British Journal of Pharmacology

Volumn 166, Issue 4, 2012, Pages 1211-1224

  Armogida, Marta ^a   Nisticò, Robert ^a,b   Mercuri, Nicola Biagio ^a,c  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

brain ischaemia; catalase; electrophysiology; hydrogen peroxide; neuroprotection

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; SUPEROXIDE DISMUTASE;

BRAIN ISCHEMIA; CELL FUNCTION; CONCENTRATION (PARAMETERS); CORPUS STRIATUM; DISEASE MODEL; DRUG TARGETING; ENZYME ACTIVITY; ENZYME MODIFICATION; HIPPOCAMPUS; HUMAN; HYDROGEN PEROXIDE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; METABOLIC PARAMETERS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; ANTIOXIDANTS; BRAIN ISCHEMIA; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HIPPOCAMPUS; HUMANS; HYDROGEN PEROXIDE; MOLECULAR TARGETED THERAPY; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOREDUCTASES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 84861309322     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01912.x     Document Type: Review

References (139)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Amantea D, Marrone MC, Nisticò R, Federici M, Bagetta G, Bernardi G, et al,. (2009). Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. Int Rev Neurobiol 85: 363-374.
3. 2 gradients across biomembranes. FEBS Lett 475: 121-126.
4. Appleman D, Heim WG, Pyfrom HT, (1956). Effects of 3-amino-1, 2, 4-triazole (AT) on catalase and other compounds. Am J Physiol 186: 19-23.
5. Armogida M, Spalloni A, Amantea D, Nutini M, Petrelli F, Longone P, et al,. (2011). On the protective role of catalase against cerebral ischemia in vitro and in vivo. Int J Immunopathol Pharmacol 24: 735-747.
6. Armstead WM, Mirro R, Thelin OP, Shibata M, Zuckerman SL, Shanklin DR, et al,. (1992). Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets. Stroke 23: 755-762.
7. Auerbach JM, Segal M, (1997). Peroxide modulation of slow onset potentiation in rat hippocampus. J Neurosci 17: 8695-8701.
8. 2. J Neurosci 23: 2744-2750.
9. Avshalumov MV, MacGregor DG, Sehgal LM, Rice ME, (2004). The glial antioxidant network and neuronal ascorbate: protective yet permissive for H(2)O(2) signaling. Neuron Glia Biol 1: 365-376.
10. Avshalumov MV, Chen BT, Kõos T, Tepper JM, Rice ME, (2005). Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci 25: 4222-4231.
11. 2 generation in striatal medium spiny neurons, but not dopamine axons: one source of a retrograde signal that can inhibit dopamine release. J Neurophysiol 100: 1590-1601.
12. Baker K, Bucay-Marcus C, Huffman C, Kruk H, Malfroy B, Doctrow SR, (1998). Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 284: 215-221.
13. Bao L, Avshalumov MV, Patel JC, Lee CR, Miller EW, Chang CJ, et al,. (2009). Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling. J Neurosci 29: 9002-9010.
14. Bienert GP, Schjoerring JK, Jahn TP, (2006). Membrane transport of hydrogen peroxide. Biochim Biophys Acta 1758: 994-1003.
15. Bienert GP, Møller AL, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK, et al,. (2007). Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 282: 1183-1192.
16. Boveris A, Chance B, (1973). The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134: 707-716.
17. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al,. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
18. Cai H, (2005). Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 68: 26-36.
19. Castillo M, Toledo-Pereyra LH, Shapiro E, Guerra E, Prough D, Frantzi P, (1990). Protective effect of allopurinol, catalase, or superoxide dismutase in ischemic rat liver. Transplant Proc 22: 490-491.
20. Chan PH, Kamii H, Yang GY, Gafni J, Epstein CJ, Carlson E, et al,. (1993). Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport 5: 293-296.
21. Chang S, Jiang X, Zhao C, Lee C, Ferriero DM, (2008). Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci Lett 441: 134-138.
22. Chaudiere J, Wilhelmsen EC, Tappel AL, (1984). Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. J Biol Chem 259: 1043-1050.
23. Chen B, Tang L, (2011). Protective effects of catalase on retinal ischemia/reperfusion injury in rats. Exp Eye Res 93: 599-606.
24. 2 is a novel, endogenous modulator of synaptic dopamine release. J Neurophysiol 85: 2468-2476.
25. Chen L, Xu B, Liu L, Luo Y, Yin J, Zhou H, et al,. (2010). Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. Lab Invest 90: 762-773.
26. Cohen G, (1994). Enzymatic/nonenzymatic sources of oxyradicals and regulation of antioxidant defenses. Ann N Y Acad Sci 738: 8-14.
27. Colton CA, Fagni L, Gilbert D, (1989). The action of hydrogen peroxide on paired pulse and long-term potentiation in the hippocampus. Free Radic Biol Med 7: 3-8.
28. Crack PJ, Taylor JM, Flentjar NJ, de Haan J, Hertzog P, Iannello RC, et al,. (2001). Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 78: 1389-1399.
29. D'Autréaux B, Toledano MB, (2007). ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824.
30. Doctrow SR, Huffman K, Marcus CB, Tocco G, Malfroy E, Adinolfi CA, et al,. (2002). Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J Med Chem 45: 4549-4558.
31. Dringen R, Pawlowski PG, Hirrlinger J, (2005). Peroxide detoxification by brain cells. J Neurosci Res 79: 157-165.
32. Durukan A, Tatlisumak T, (2009). Ischemic stroke in mice and rats. Methods Mol Biol 573: 95-114.
33. Farr CH, (1988). Physiological and biochemical responses to intravenous hydrogen peroxide in man. J Adv Med l: 113-l29.
34. Finkel T, (2011). Signal transduction by reactive oxygen species. J Cell Biol 194: 7-15.
35. Finney JW, Urschel HC, Balla GA, Race GJ, Jay BE, Pingree HP, et al,. (1967). Protection of the ischemic heart with DMSO alone or DMSO with hydrogen peroxide. Ann N Y Acad Sci 141: 231-241.
36. Fisher M, (2011). New approaches to neuroprotective drug development. Stroke 42: S24-S27.
37. Flamm ES, Demopoulus HB, Seligman ML, Poser RG, Ranoshoff J, (1978). Free radicals in cerebral ischemia. Stroke 9: 445-447.
38. Forsman M, Fleischer JE, Milde JH, Stehen PA, Michenfelder JD, (1988). Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog. Acta Anaesthesiol Scand 32: 152-155.
39. Fowler JC, (1997). Hydrogen peroxide opposes the hypoxic depression of evoked synaptic transmission in rat hippocampal slices. Brain Res 766: 255-258.
40. French LK, Horowitz BZ, McKeown NJ, (2010). Hydrogen peroxide ingestion associated with portal venous gas and treatment with hyperbaric oxygen: a case series and review of the literature. Clin Toxicol 48: 533-538.
41. Fridovich I, (1995). Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112.
42. Fujimura M, Morita-Fujimura Y, Noshita N, Sugawara T, Kawase M, Chan PH, (2000). The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J Neurosci 20: 2817-2824.
43. Fujimura M, Morita-Fujimura Y, Copin J, Yoshimoto T, Chan PH, (2001). Reduction of copper,zinc-superoxide dismutase in knockout mice does not affect edema or infarction volumes and the early release of mitochondrial cytochrome c after permanent focal cerebral ischemia. Brain Res 889: 208-213.
44. Furling D, Ghribi O, Lahsaini A, Mirault ME, Massicotte G, (2000). Impairment of synaptic transmission by transient hypoxia in hippocampal slices: improved recovery in glutathione peroxidase transgenic mice. Proc Natl Acad Sci U S A 97: 4351-4356.
45. Furuichi T, Liu W, Shi H, Miyake M, Liu KJ, (2005). Generation of hydrogen peroxide during brief oxygen-glucose deprivation induces preconditioning neuronal protection in primary cultured neurons. J Neurosci Res 79: 816-824.
46. Gardner TJ, Stewart JR, Casale AS, Downey JM, Chambers DE, (1983). Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery 94: 423-427.
47. Gáspár T, Domoki F, Lenti L, Institoris A, Snipes JA, Bari F, et al,. (2009). Neuroprotective effect of adenoviral catalase gene transfer in cortical neuronal cultures. Brain Res 1270: 1-9.
48. Geracitano R, Tozzi A, Berretta N, Florenzano F, Guatteo E, Viscomi MT, et al,. (2005). Protective role of hydrogen peroxide in oxygen-deprived dopaminergic neurones of the rat substantia nigra. J Physiol 568: 97-110.
49. 2-mediated modulation of cytosolic signaling and organelle function in rat hippocampus. Pflugers Arch 458: 937-952.
50. Giaginis C, Tsourouflis G, Theocharis S, (2008). Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury. Curr Mol Med 8: 562-579.
51. Giorgio M, Trinei M, Migliaccio E, Pelicci PG, (2007). Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8: 722-728.
52. Gõth L, (2006). [The hydrogen peroxide paradox]. Orv Hetil 147: 887-893.
53. Gough DR, Cotter TG, (2011). Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis 2: e213.
54. Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF, (1978). Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653.
55. Green S, (1998). Oxygenation therapy: unproven treatments for cancer and AIDS. Sci Rev Altern Med 2: 6-13. Available at: (accessed 27 July 2011).
56. Groeger G, Quiney C, Cotter TG, (2009). Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 11: 2655-2671.
57. Gu W, Zhao H, Yenari MA, Sapolsky RM, Steinberg GK, (2004). Catalase over-expression protects striatal neurons from transient focal cerebral ischemia. Neuroreport 15: 413-416.
58. Halliwell B, (1992). Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623.
59. Halliwell B, (1999). Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 31: 261-272.
60. Halliwell B, Gutteridge JMC, (1999). Free radicals, other reactive species and disease. In:, Halliwell B, Gutteridge JMC, (eds). Free Radicals in Biology and Medicine. Clarendon Press: Oxford, pp. 617-783.
61. Halliwell B, Clement MV, Long LH, (2000). Hydrogen peroxide in the human body. FEBS Lett 486: 10-13.
62. van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM, (2004). FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 279: 28873-28879.
63. Huang GQ, Wang JN, Tang JM, Zhang L, Zheng F, Yang JY, et al,. (2011). The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury. J Transl Med 9: 73.
64. 2 in vitro. Brain Res 671: 181-186.
65. Ishibashi N, Prokopenko O, Weisbrot-Lefkowitz M, Reuhl KR, Mirochnitchenko O, (2002). Glutathione peroxidase inhibits cell death and glial activation following experimental stroke. Brain Res Mol Brain Res 109: 34-44.
66. Kamsler A, Segal M, (2003). Hydrogen peroxide modulation of synaptic plasticity. J Neurosci 23: 269-276.
67. Katsuki H, Nakanishi C, Saito H, Matsuki N, (1997). Biphasic effect of hydrogen peroxide on field potentials in rat hippocampal slices. Eur J Pharmacol 337: 213-218.
68. Kaundal RK, Sharma SS, (2010). Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents. Drug News Perspect 23: 241-256.
69. Kim DW, Jeong HJ, Kang HW, Shin MJ, Sohn EJ, Kim MJ, et al,. (2009). Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage. Free Radic Biol Med 47: 941-952.
70. Kim GW, Kondo T, Noshita N, Chan PH, (2002). Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 33: 809-815.
71. Kirino T, (1982). Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239: 57-69.
72. Klann E, Thiels E, (1999). Modulation of protein kinases and proteinc phosphatases by reactive oxygen species: implications for hippocampal synaptic plasticity. Prog Neuropsychopharmacol Biol Psychiatry 23: 359-376.
73. Lees GJ, Leong W, (1995). The sodium-potassium ATPase inhibitor ouabain is neurotoxic in the rat substantia nigra and striatum. Neurosci Lett 188: 113-116.
74. 2 in the brain by microdialysis. Brain Res Brain Res Protoc 3: 33-36.
75. Lipsanen A, Jolkkonen J, (2011). Experimental approaches to study functional recovery following cerebral ischemia. Cell Mol Life Sci 68: 3007-3017.
76. Lipton P, (1999). Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568.
77. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY, (1989). Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol Heart Circ Physiol 256: H589-H593.
78. Love IN, (1888). Peroxide of Hydrogen as a remedial agent. JAMA 10: 262-265.
79. Ma HP, (2011). Hydrogen peroxide stimulates the epithelial sodium channel through a phosphatidylinositide 3-kinase-dependent pathway. J Biol Chem 286: 32444-32453.
80. Macrae I, (2011). Preclinical stroke research-advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol 164: 1062-1078.
81. Margoliash E, Novogrodsky A, (1958). A study of the inhibition of catalase by 3-amino-1:2:4:-triazole. Biochem J 68: 468-475.
82. Mele J, Van Remmen H, Vijg J, Richardson A, (2006). Characterization of transgenic mice that overexpress both copper zinc superoxide dismutase and catalase. Antioxid Redox Signal 8: 628-638.
83. Mercuri NB, Bonci A, Calabresi P, Stratta F, Bernardi G, (1994). Responses of rat mesencephalic dopaminergic neurons to a prolonged period of oxygen deprivation. Neuroscience 63: 757-764.
84. Miller EW, Albers AE, Pralle A, Isacoff EY, Chang CJ, (2005). Boronate-based fluorescent probes for imaging cellular hydrogen peroxide. J Am Chem Soc 127: 16652-16659.
85. Miller EW, Tulyathan O, Isacoff EY, Chang CJ, (2007). Molecular imaging of hydrogen peroxide produced for cell signaling. Nat Chem Biol 3: 263-267.
86. Miller EW, Dickinson BC, Chang CJ, (2010). Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci U S A 107: 15681-15686.
87. Mishina NM, Tyurin-Kuzmin PA, Markvicheva KN, Vorotnikov AV, Tkachuk VA, Laketa V, et al,. (2011). Does cellular hydrogen peroxide diffuse or act locally? Antioxid Redox Signal 14: 1-7.
88. Murakami K, Kondo T, Kawasr M, Li Y, Sato S, Chen SF, et al,. (1998). Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18: 205-213.
89. Nisticò R, Piccirilli S, Cucchiaroni ML, Armogida M, Guatteo E, Giampà C, et al,. (2008). Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. Br J Pharmacol 153: 1022-1029.
90. Oliveira-Marques V, Marinho HS, Cyrne L, Antunes F, (2009). Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid Redox Signal 11: 2223-2243.
91. Oliver TH, Cantab BC, Murphy DV, (1920). Influenzal pneumonia: the intravenous injection of hydrogen peroxide. Lancet 1: 432-433.
92. Pellmar TC, (1987). Peroxide alters neuronal excitability in the CA1 region of guinea-pig hippocampus in vitro. Neuroscience 23: 447-456.
93. Pulsinelli WA, Brierley JB, Plum F, (1982). Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11: 491-498.
94. 2, a necessary evil for cell signaling. Science 312: 1882-1883.
95. Rhee SG, Bae YS, Lee SR, Kwon J, (2000). Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: pe1.
96. 2: a dynamic neuromodulator. Neuroscientist 17: 389-406.
97. Schoenbein CF, (1856). On ozone and oronic actions in mushrooms. Phil Mag 11: 137-141.
98. Sen CK, Packer L, (1996). Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720.
99. Sharma SS, Gupta S, (2007). Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation. Eur J Pharmacol 561: 72-79.
100. Sheng H, Bart RD, Oury TD, Pearlstein RD, Crapo JD, Warner DS, (1999a). Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience 88: 185-191.
101. Sheng H, Brody T, Pearlstein RD, Crapo J, Warner DS, (1999b). Extracellular superoxide dismutase deficient mice have decreased resistance to focal cerebral ischemia. Neurosci Lett 267: 13-17.
102. Sheng H, Kudo M, Mackensen GB, Pearlstein RD, Crapo JD, Warner DS, (2000). Mice overexpressing extracellular superoxide dismutase have increased tolerance to global cerebral ischemia. Exp Neurol 163: 392-398.
103. Shimizu K, Rajapakse N, Horiguchi T, Payne RM, Busija DW, (2003). Protective effect of a new nonpeptidyl mimetic of SOD, M40401, against focal cerebral ischemia in the rat. Brain Res 963: 8-14.
104. Simerabet M, Robin E, Aristi I, Adamczyk S, Tavernier B, Vallet B, et al,. (2008). Preconditioning by an in situ administration of hydrogen peroxide: involvement of reactive oxygen species and mitochondrial ATP-dependent potassium channel in a cerebral ischemia-reperfusion model. Brain Res 1240: 177-184.
105. Sims NR, Anderson MF, (2002). Mitochondrial contributions to tissue damage in stroke. Neurochem Int 40: 511-526.
106. Smith ML, Auer RN, Siesjö BK, (1984). The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol 64: 319-332.
107. Stone JR, Yang S, (2006). Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8: 243-270.
108. St-Pierre J, Drori S, Uldry M, Selvaggi JM, Rhee J, Jäger S, et al,. (2006). Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397-408.
109. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299.
110. Thénard LJ, (1818). Observations sur des nouvelles combinaisons entre l'oxigène et divers acides. Ann Phys 8: 306-312.
111. Tipton KF, (1968). The reaction pathway of pig brain mitochondrial monoamine oxidase. Eur J Biochem 5: 316-320.
112. Tipton KF, Boyce S, O'Sullivan J, Davey GP, Healy J, (2004). Monoamine oxidases: certainties and uncertainties. Curr Med Chem 11: 1965-1982.
113. Topper JN, Cai J, Falb D, Gimbrone MA Jr, (1996). Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 93: 10417-10422.
114. Traystman RJ, Kirsch JR, Koehler RC, (1991). Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 71: 1185-1195.
115. Undyala V, Terlecky SR, Vander Heide RS, (2011). Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury. Cardiovasc Pathol 20: 272-280.
116. Urschel HC Jr, (1967). Progress in cardiovascular surgery. Cardiovascular effects of hydrogen peroxide: current status. Dis Chest 51: 180-192.
117. Ushitora M, Sakurai F, Yamaguchi T, Nakamura S, Kondoh M, Yagi K, et al,. (2010). Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectors. J Control Release 142: 431-437.
118. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J, (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84.
119. Vanella A, Di Giacomo C, Sorrenti V, Russo A, Castorina C, Campisi A, et al,. (1993). Free radical scavenger depletion in post-ischemic reperfusion brain damage. Neurochem Res 18: 1337-1340.
120. Veal EA, Day AM, Morgan BA, (2007). Hydrogen peroxide sensing and signaling. Mol Cell 26: 1-14.
121. Walton K, Fulton B, (1983). Hydrogen peroxide as a source of molecular oxygen for in vitro mammalian CNS preparations. Brain Res 278: 387-393.
122. Wang H, Cheng E, Brooke S, Chang P, Sapolsky R, (2003). Over-expression of antioxidant enzymes protects cultured hippocampal and cortical neurons from necrotic insults. J Neurochem 87: 1527-1534.
123. Warner DS, Sheng H, Batinić-Haberle I, (2004). Oxidants, antioxidants and the ischemic brain. J Exp Biol 207: 3221-3231.
124. Watt BE, Proudfoot AT, Vale JA, (2004). Hydrogen peroxide poisoning. Toxicol Rev 23: 51-57.
125. Wechsler LR, (2011). Intravenous thrombolytic therapy for acute ischemic stroke. N Engl J Med 364: 2138-2146.
126. Weisbrot-Lefkowitz M, Reuhl K, Perry B, Chan PH, Inouye M, Mirochnitchenko O, (1998). Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res Mol Brain Res 53: 333-338.
127. White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, et al,. (2000). Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179: 1-33.
128. Willhelm SF, (1989). Personal Communication from Fr. Richard Willhelm. Enlightened Catholic Health Organization (ECHO): Naples, FL.
129. Winterbourn CC, (2008). Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4: 278-286.
130. Wolffenstein R, (1894). Concentration und Destillation von Wasserstoffsuperoxyd. Ber Dtsch Chem Ges 27: 3307-3312.
131. Xiao-Qing T, Jun-Li Z, Yu C, Jian-Qiang F, Pei-Xi C, (2005). Hydrogen peroxide preconditioning protects PC12 cells against apoptosis induced by dopamine. Life Sci 78: 61-66.
132. Yabe Y, Nishikawa M, Tamada A, Takakura Y, Hashida M, (1999). Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 289: 1176-1184.
133. Yaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H, et al,. (2003). Protective effects of hydrogen peroxide against ischemia/ reperfusion injury in perfused rat hearts. Circ J 67: 253-258.
134. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, et al,. (1994). Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25: 165-170.
135. Yano T, Ushijima K, Terasaki H, (1998). Failure of glutathione peroxidase to reduce transient ischemic injury in the rat hippocampal CA1 subfield. Resuscitation 39: 91-98.
136. 2 toxicity. J Appl Physiol 57: 1674-1681.
137. Zemlyak I, Brooke SM, Singh MH, Sapolsky RM, (2009). Effects of overexpression of antioxidants on the release of cytochrome c and apoptosis-inducing factor in the model of ischemia. Neurosci Lett 453: 182-185.
138. Zhou M, Baudry M, (2009). EUK-207, a superoxide dismutase/catalase mimetic, is neuroprotective against oxygen/glucose deprivation-induced neuronal death in cultured hippocampal slices. Brain Res 1247: 28-37.
139. Zhou M, Dominguez R, Baudry M, (2007). Superoxide dismutase/catalase mimetics but not MAP kinase inhibitors are neuroprotective against oxygen/glucose deprivation-induced neuronal death in hippocampus. J Neurochem 103: 2212-2223.